Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Cancers

NCT07233928 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT07233928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07233928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Cancers
Lead sponsor
Institut Claudius Regaud
Phase
Not applicable
Overall status
Recruiting
Start date
February 6, 2026
Completion date
February 6, 2035
Enrollment
1,050 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early breast cancer, metastatic breast cancer